CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations
Open accessThe DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index; none of the 42 sources its claims cite is checked for support yet.
Abstract
CBS domains are defined as sequence motifs that occur in several different proteins in all kingdoms of life. Although thought to be regulatory, their exact functions have been unknown. However, their importance was underlined by findings that mutations in conserved residues within them cause a variety of human hereditary diseases, including (with the gene mutated in parentheses): Wolff-Parkinson-White syndrome (gamma 2 subunit of AMP-activated protein kinase); retinitis pigmentosa (IMP dehydrogenase-1); congenital myotonia, idiopathic generalized epilepsy, hypercalciuric nephrolithiasis, and classic Bartter syndrome (CLC chloride channel family members); and homocystinuria (cystathionine beta-synthase). AMP-activated protein kinase is a sensor of cellular energy status that is activated by AMP and inhibited by ATP, but the location of the regulatory nucleotide-binding sites (which are prime targets for drugs to treat obesity and diabetes) was not characterized. We now show that tandem pairs of CBS domains from AMP-activated protein kinase, IMP dehydrogenase-2, the chloride channel CLC2, and cystathionine beta-synthase bind AMP, ATP, or S-adenosyl methionine,while mutations that cause hereditary diseases impair this binding. This shows that tandem pairs of CBS domains act, in most cases, as sensors of cellular energy status and, as such, represent a newly identified class of binding domain for adenosine derivatives.
Overview
CoChat Summary
## TL;DR
This paper shows that tandem CBS domain pairs act as allosteric binding modules for adenosine-related ligands, including AMP and ATP in AMPK, ATP in IMPDH and CLC2, and SAM in cystathionine β-synthase. It also shows that disease-associated mutations in these domains weaken ligand binding and, in AMPK, impair AMP-dependent activation.
## Key findings
- For AMPKγ2, the isolated CBS1-2 pair bound 1 AMP molecule with Kd = 53 ± 5 µM, and the CBS3-4 pair bound 1 AMP molecule with Kd = 104 ± 10 µM; the full CBS1-4 construct bound 2 AMP molecules with B0.5 = 61 ± 2 µM and Hill coefficient = 2.2 ± 0.1.
- Disease mutations increased AMP binding constants for AMPKγ2 CBS constructs; for CBS1-4, B0.5 for AMP rose from 61 ± 2 µM (WT) to 158 ± 9 µM (R302Q), 725 ± 36 µM (H383R), 1,360 ± 47 µM (T400N), and 2,800 ± 220 µM (R531G).
- In recombinant α1β1γ2 AMPK heterotrimers, the A0.5 for AMP activation increased in the same order as binding defects: WT 7 ± 3 µM, L ins 9 ± 4 µM, R302Q 23 ± 6 µM, H383R 51 ± 40 µM, T400N 95 ± 32 µM, and R531G >100 µM; the paper also states the WT α1β1γ1, α1β1γ2, and α1β1γ3 complexes were stimulated 3.3-fold, 7.0-fold, and 1.5-fold by AMP, respectively.
- Other CBS-domain proteins showed the same pattern: IMPDH2 CBS domains bound 1 ATP molecule with Kd = 54 ± 6 µM, while the R224P mutation increased this to 450 ± 36 µM; full-length IMPDH2 bound ATP with B0.5 = 770 ± 50 µM and ATP stimulated IMPDH activity more than fourfold with A0.5 = 0.44 ± 0.05 mM and Hill coefficient = 1.3 ± 0.1; CLC2 CBS domains bound ATP with Kd = 1.06 ± 0.08 mM, and pathogenic mutations raised this to 10.4-fold (G715E) and 14-fold (G826D) higher; cystathionine β-synthase CBS domains bound SAM with Kd = 34 ± 2 µM, and D444N increased this 15-fold to 510 ± 70 µM.
## Methods
- The study cloned CBS-domain constructs from AMPKγ1, γ2, and γ3, IMPDH2, CLC2, and cystathionine β-synthase, expressed them mainly as GST fusions in bacteria, and introduced disease mutations by site-directed mutagenesis.
- Ligand binding was measured using radiolabeled AMP, ATP, or SAM with rapid filtration, and data were fit to single-site or Hill binding models; AMPK heterotrimers were also expressed in CCL13 cells and assayed for AMP-dependent activity after rapid or slow lysis.
- IMPDH2 enzymatic activity was measured by NADH formation at 340 nm in the presence or absence of ATP.
## Limitations
- The paper itself notes several unresolved issues: AMP activation of AMPK heterotrimers occurred at concentrations about tenfold lower than the B0.5 values for AMP binding to isolated CBS1-4 constructs; the three AMPKγ isoforms differed in AMP binding (20 µM, 53 µM, 125 µM) but the heterotrimers differed mainly in degree of stimulation rather than A0.5; and it states that further work is required to determine whether AMPK uses a mechanism similar to cAMP-dependent protein kinase.
- The text makes evident that some activation estimates are less precise because AMP could not be tested above 100 µM in heterotrimer assays, and the authors say the A0.5 values for H383R and T400N are less accurate, while no A0.5 could be obtained for R531G; this is an evidence-based limitation from the assay design.
- The study used purified domains and recombinant proteins in bacteria or cell culture, so direct in vivo physiology is not tested here; this is evident from the methods and experimental system, not explicitly stated as a limitation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 23 Not checked · 78 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“| AMPK- γ 2 | CBS1-2 (WT) | 1 | 53 ± 5 | - | 175 ± 20 | - |”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We now show that tandem pairs of CBS domains from AMP-activated protein kinase, IMP dehydrogenase-2, the chloride channel CLC2, and cystathionine β -synthase bind AMP, ATP, or S -adenosyl methionine,while mutations that cause hereditary diseases impair this binding.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We now show that tandem pairs of CBS domains from AMP-activated protein kinase, IMP dehydrogenase-2, the chloride channel CLC2, and cystathionine β -synthase bind AMP, ATP, or S -adenosyl methionine,while mutations that cause hereditary diseases impair this binding.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mutant still bound AMP, but the K d increased 15-fold (Figure 1c and Table 1).”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The K d for L ins was not significantly different from that for the WT.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
49 more claims
Create a free account to see all 101 claims and to verify the 42 references still open.
- It may state two separate claims as one. 38
- The quote only partly states this claim. 1
- Probably not a substantial claim. 12
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Figure 4
“Binding of ATP by GST fusions of the isolated CBS domain pair (residues 112-232) ( a ) and full-length IMPDH2 (residues 1-514) ( b ).”
§ Methods
“The IMPDH2 constructs were polyhistidine-tagged and were purified on chelating Sepharose (Pharmacia, Chalfont St. Giles, United Kingdom) charged with 50 mM CoCl2 according to the manufacturer's instructions.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion
“the four tandem pairs of CBS domains in the γ subunits of AMPK provide two allosteric binding sites for AMP and ATP in the heterotrimeric complex”
§ Introduction
“the three γ subunit isoforms of AMPK, and their homologues in lower eukaryotes, are unique among eukaryotic proteins in having four tandem domains”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Figure 3
“For the constructs from γ 1, γ 2, and γ 3, the B0.5 values for AMP were 20, 53, and 125 µ m, respectively.”
§ Methods
“| | CBS1-4 (WT) | 2 | 61 ± 2 | 2.2 ± 0.1 | 257 ± 14 | 2.2 ± 0.2 |”
Citations
Cites
1 retracted
Haug, K., Warnstedt, M., Alekov, A. K., Sander, T., Ramírez, A., Poser, B., Maljevic, S., Hebeisen, S., Kubisch, C., Rebstock, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1121 · Cited by 294
RetractedThe Pfam Protein Families Database
Bateman, A. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.276 · Cited by 14,000
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Nicholls, A., Sharp, K. A., & Honig, B. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110407 · Cited by 5,240
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053 · cited 1×
“It is also activated by the antidiabetic drugs metformin and rosiglitazone (21–23), and by the adipocyte-derived hormones leptin and adiponectin (24, 25).”
BackgroundCorton, J. M., Gillespie, J. G., Hawley, S. A., & Hardie, D. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0558k.x · Cited by 1,230
Self-citationFryer, L. G. D., Parbu-Patel, A., & Carling, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202489200 · Cited by 1,029
Merrill, G. F., Kurth, E. J., Hardie, D. G., & Winder, W. W. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1107 · Cited by 1,025
Self-citation
Research works printed but not linked: 4
- Winder, 1996, Am. J. Physiol., 270, E299
- Merrill, 1997, Am. J. Physiol., 273, E1107
- Winder, 1999, Am. J. Physiol., 277, E1
- Hardie, 2000, Methods Mol. Biol., 99, 63
Cited by
Items 101–200 of 752
Hardie, D. G. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390001 · Cited by 172
Self-citationRegulation of AMP-activated protein kinase by natural and synthetic activators
Grahame Hardie, D. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.06.002 · Cited by 174
Self-citationDifferential regulation by AMP and ADP of AMPK complexes containing different γ subunit isoforms
Ross, F. A., Jensen, T. E., & Hardie, D. G. (2016) · Biochemical Journal · doi:10.1042/bj20150910 · Cited by 172
Self-citationZong, Y., Zhang, C.-S., Li, M., Wang, W., Wang, Z., Hawley, S. A., Ma, T., Feng, J.-W., Tian, X., Qi, Q., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0163-6 · Cited by 171
Self-citationAMP-Activated Protein Kinase: A Key Stress Signaling Pathway in the Heart
Young, L. H., Li, J., Baron, S. J., & Russell, R. R. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.04.005 · Cited by 166
Bateman domains and adenosine derivatives form a binding contract
Kemp, B. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420846 · Cited by 165
AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease
Wong, A. K. F., Howie, J., Petrie, J. R., & Lang, C. C. (2009) · Clinical Science · doi:10.1042/cs20080066 · Cited by 165
Intrasteric control of AMPK via the γ1 subunit AMP allosteric regulatory site
Adams, J., Chen, Z., Van Denderen, B. J. W., Morton, C. J., Parker, M. W., Witters, L. A., Stapleton, D., & Kemp, B. E. (2004) · Protein Science · doi:10.1110/ps.03340004 · Cited by 165
Qi, J., Gong, J., Zhao, T., Zhao, J., Lam, P., Ye, J., Li, J. Z., Wu, J., Zhou, H., & Li, P. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.92 · Cited by 164
“The g subunit of AMPK contains four cystathionine beta-synthase repeats that bind to AMP or ATP in a mutually exclusive manner (Scott et al, 2004).”
BackgroundCrystal structure of the heterotrimer core of Saccharomyces cerevisiae AMPK homologue SNF1
Amodeo, G. A., Rudolph, M. J., & Tong, L. (2007) · Nature · doi:10.1038/nature06127 · Cited by 163
AMP‐activated protein kinase and cancer
Wang, W., & Guan, K. ‐. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01980.x · Cited by 160
Molecular Pathways: Is AMPK a Friend or a Foe in Cancer?
Hardie, D. G. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3300 · Cited by 161
Self-citationGenome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
Ben Jehuda, R., Shemer, Y., & Binah, O. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9811-3 · Cited by 161
Role of the energy sensor AMP-activated protein kinase in renal physiology and disease
Hallows, K. R., Mount, P. F., Pastor-Soler, N. M., & Power, D. A. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00005.2010 · Cited by 159
The CBS Domain: A Protein Module with an Emerging Prominent Role in Regulation
Baykov, A. A., Tuominen, H. K., & Lahti, R. (2011) · ACS Chemical Biology · doi:10.1021/cb200231c · Cited by 156
The Role of Cystathionine β-Synthase in Homocysteine Metabolism
Jhee, K.-H., & Kruger, W. D. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.813 · Cited by 155
Nucleotide recognition by the cytoplasmic domain of the human chloride transporter ClC-5
Meyer, S., Savaresi, S., Forster, I. C., & Dutzler, R. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1188 · Cited by 172
Burwinkel, B., Scott, J. W., Bührer, C., van Landeghem, F. K. H., Cox, G. F., Wilson, C. J., Hardie, D. G., & Kilimann, M. W. (2005) · The American Journal of Human Genetics · doi:10.1086/430840 · Cited by 168
Self-citationAMPK: a cellular energy sensor primarily regulated by AMP
Gowans, G. J., & Hardie, D. G. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130244 · Cited by 151
Self-citationHighly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy
Liao, L.-X., Song, X.-M., Wang, L.-C., Lv, H.-N., Chen, J.-F., Liu, D., Fu, G., Zhao, M.-B., Jiang, Y., Zeng, K.-W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706778114 · Cited by 149
Increased transsulfuration mediates longevity and dietary restriction in Drosophila
Kabil, H., Kabil, O., Banerjee, R., Harshman, L. G., & Pletcher, S. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102008108 · Cited by 147
Energy sensing by the AMP-activated protein kinase and its effects on muscle metabolism
Hardie, D. G. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665110003915 · Cited by 146
Self-citationA sensor for intracellular ionic strength
Biemans-Oldehinkel, E., Mahmood, N. A. B. N., & Poolman, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603871103 · Cited by 144
Sidhu, J. S., Rajawat, Y. S., Rami, T. G., Gollob, M. H., Wang, Z., Yuan, R., Marian, A. J., DeMayo, F. J., Weilbacher, D., Taffet, G. E., et al. (2005) · Circulation · doi:10.1161/01.cir.0000151291.32974.d5 · Cited by 144
Cell Biology and Physiology of CLC Chloride Channels and Transporters
Stauber, T., Weinert, S., & Jentsch, T. J. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110038 · Cited by 145
Cellular energy sensing and signaling by AMP-activated protein kinase
Winder, W. W., & Thomson, D. M. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0008-7 · Cited by 154
Kennan, A., Aherne, A., & Humphries, P. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.12.001 · Cited by 156
Fogarty, S., Hawley, S. A., Green, K. A., Saner, N., Mustard, K. J., & Hardie, D. G. (2010) · Biochemical Journal · doi:10.1042/bj20091372 · Cited by 140
Self-citationAMPK: A cellular metabolic and redox sensor. A minireview
Shirwany, N. (2014) · Frontiers in Bioscience · doi:10.2741/4218 · Cited by 139
Tzatsos, A., & Tsichlis, P. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610101200 · Cited by 140
AMP‐activated protein kinase enhances the phagocytic ability of macrophages and neutrophils
Bae, H., Zmijewski, J. W., Deshane, J. S., Tadie, J., Chaplin, D. D., Takashima, S., & Abraham, E. (2011) · The FASEB Journal · doi:10.1096/fj.11-190587 · Cited by 138
CBS domains: Ligand binding sites and conformational variability
Ereño‐Orbea, J., Oyenarte, I., & Martínez‐Cruz, L. A. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.10.008 · Cited by 146
The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde?
Vara-Ciruelos, D., Russell, F. M., & Hardie, D. G. (2019) · Open Biology · doi:10.1098/rsob.190099 · Cited by 135
Self-citationCLC chloride channels and transporters
Jentsch, T. J., Neagoe, I., & Scheel, O. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.002 · Cited by 154
Iseli, T. J., Walter, M., van Denderen, B. J. W., Katsis, F., Witters, L. A., Kemp, B. E., Michell, B. J., & Stapleton, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412993200 · Cited by 134
AMP-activated protein kinase undergoes nucleotide-dependent conformational changes
Chen, L., Wang, J., Zhang, Y., Yan, S. F., Neumann, D., Schlattner, U., Wang, Z., & Wu, J. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2319 · Cited by 152
Galactose metabolic genes in yeast respond to a ratio of galactose and glucose
Escalante-Chong, R., Savir, Y., Carroll, S. M., Ingraham, J., Wang, J., Marx, C. J., & Springer, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418058112 · Cited by 133
Role of AMP-activated protein kinase in healthy and diseased hearts
Dolinsky, V. W., & Dyck, J. R. B. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00329.2006 · Cited by 131
Expanding roles for AMP‐activated protein kinase in neuronal survival and autophagy
Poels, J., Spasić, M. R., Callaerts, P., & Norga, K. K. (2009) · BioEssays · doi:10.1002/bies.200900003 · Cited by 130
Gruzman, A., Babai, G., & Sasson, S. (2009) · The Review of Diabetic Studies · doi:10.1900/rds.2009.6.13 · Cited by 128
Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story
Naffouje, R., Grover, P., Yu, H., Sendilnathan, A., Wolfe, K., Majd, N., Smith, E. P., Takeuchi, K., Senda, T., Kofuji, S., et al. (2019) · Cancers · doi:10.3390/cancers11091346 · Cited by 138
Cytoplasmic ATP-sensing Domains Regulate Gating of Skeletal Muscle ClC-1 Chloride Channels
Bennetts, B., Rychkov, G. Y., Ng, H.-L., Morton, C. J., Stapleton, D., Parker, M. W., & Cromer, B. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502890200 · Cited by 127
Rubenstein, E. M., McCartney, R. R., Zhang, C., Shokat, K. M., Shirra, M. K., Arndt, K. M., & Schmidt, M. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707957200 · Cited by 134
Regulation of the Interaction of Inosine Monophosphate Dehydrogenase with Mycophenolic Acid by GTP
Ji, Y.-S., Gu, J., Makhov, A. M., Griffith, J. D., & Mitchell, B. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507056200 · Cited by 127
Krawiec, B. J., Nystrom, G. J., Frost, R. A., Jefferson, L. S., & Lang, C. H. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00622.2006 · Cited by 123
AMP‐activated protein kinase – a sensor of glycogen as well as AMP and ATP?
McBride, A., & Hardie, D. G. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01975.x · Cited by 122
Self-citationAMPK in cardiovascular health and disease
Shirwany, N. A., & Zou, M.-H. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.139 · Cited by 122
Kushwaha, H. R., Singh, A. K., Sopory, S. K., Singla-Pareek, S. L., & Pareek, A. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-200 · Cited by 147
The role of autophagy in cardiovascular pathology
Gatica, D., Chiong, M., Lavandero, S., & Klionsky, D. J. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab158 · Cited by 126
Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation
Johnson, M. C., & Kollman, J. M. (2020) · eLife · doi:10.7554/elife.53243 · Cited by 113
Jibb, L., & Richards, J. G. (2008) · Journal of Experimental Biology · doi:10.1242/jeb.019117 · Cited by 130
AMP-Activated Protein Kinase: A Master Switch in Glucose and Lipid Metabolism
Hardie, D. G. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000021433.63915.bb · Cited by 127
Self-citationKoutmos, M., Kabil, Ö., Smith, J. L., & Banerjee, R. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011448107 · Cited by 116
CLC chloride channels and transporters: a biophysical and physiological perspective
Zifarelli, G., & Pusch, M. (2006) · Springer eBooks · doi:10.1007/112_2006_0605 · Cited by 121
Niu, W., Yadav, P. K., Adamec, J., & Banerjee, R. V. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5891 · Cited by 125
Molecular Mechanisms of Muscle Plasticity with Exercise
Hoppeler, H., Baum, O., Lurman, G., & Mueller, M. (2011) · Comprehensive Physiology · doi:10.1002/cphy.c100042 · Cited by 111
Neither LKB1 Nor AMPK Are the Direct Targets of Metformin
Hardie, D. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.032 · Cited by 113
Self-citationEwart, M., & Kennedy, S. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.11.002 · Cited by 120
Crystal Structure of the Cytoplasmic Domain of the Chloride Channel ClC-0
Meyer, S., & Dutzler, R. (2006) · Structure · doi:10.1016/j.str.2005.10.008 · Cited by 107
Nerstedt, A., Johansson, A., Andersson, C. X., Cansby, E., Smith, U., & Mahlapuu, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1856-z · Cited by 106
McGee, S. L., Mustard, K. J., Hardie, D. G., & Baar, K. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.143685 · Cited by 105
“When cellular energy is decreased, causing a drop in the ATP : ADP ratio, the consequent rise in the AMP : ATP ratio produced by adenylate kinase results in increased binding of AMP to two sites on the γ subunit of AMPK (Scott et al. 2004).”
BackgroundSelf-citationSingh, A. K., Kumar, R., Pareek, A., Sopory, S. K., & Singla-Pareek, S. L. (2012) · Molecular Biotechnology · doi:10.1007/s12033-011-9487-2 · Cited by 115
Taylor, E. B., Lamb, J. D., Hurst, R. W., Chesser, D. G., Ellingson, W. J., Greenwood, L. J., Porter, B. B., Herway, S. T., & Winder, W. W. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00237.2005 · Cited by 103
Role of AMP-Activated Protein Kinase in the Molecular Adaptation to Endurance Exercise
WINDER, W. W., TAYLOR, E. B., & THOMSON, D. M. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000233798.62153.50 · Cited by 102
Evolution of allostery in the cyclic nucleotide binding module
Kannan, N., Wu, J., Anand, G. S., Yooseph, S., Neuwald, A. F., Venter, J. C., & Taylor, S. S. (2007) · Genome Biology · doi:10.1186/gb-2007-8-12-r264 · Cited by 101
Hinson, J. T., Chopra, A., Lowe, A., Sheng, C. C., Gupta, R. M., Kuppusamy, R., O’Sullivan, J., Rowe, G., Wakimoto, H., Gorham, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.066 · Cited by 100
AMP-Activated Kinase Restricts Rift Valley Fever Virus Infection by Inhibiting Fatty Acid Synthesis
Moser, T. S., Schieffer, D., & Cherry, S. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002661 · Cited by 104
Ramos‐Montañez, S., Tsui, H. T., Wayne, K. J., Morris, J. L., Peters, L. E., Zhang, F., Kazmierczak, K. M., Sham, L., & Winkler, M. E. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.06082.x · Cited by 99
Coort, S. L., Bonen, A., Vusse, G. J., Glatz, J. F. C., & Luiken, J. J. F. P. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9030-5 · Cited by 114
AMPK regulation of mouse oocyte meiotic resumption in vitro
Chen, J., Hudson, E. R., Chi, M. M.-Y., Chang, A. S., Moley, K. H., Hardie, D. G., & Downs, S. M. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2005.11.039 · Cited by 110
Self-citationLützner, N., Kalbacher, H., Krones-Herzig, A., & Rösl, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042166 · Cited by 99
Synthetic energy sensor AMPfret deciphers adenylate-dependent AMPK activation mechanism
Pelosse, M., Cottet‐Rousselle, C., Bidan, C. M., Dupont, A., Gupta, K., Berger, I., & Schlattner, U. (2019) · Nature Communications · doi:10.1038/s41467-019-08938-z · Cited by 101
Buey, R. M., Ledesma‐Amaro, R., Velázquez‐Campoy, A., Balsera, M., Chagoyen, M., de Pereda, J. M., & Revuelta, J. L. (2015) · Nature Communications · doi:10.1038/ncomms9923 · Cited by 96
Pey, A. L., Majtán, T., Sánchez‐Ruiz, J. M., & Kraus, J. P. (2012) · Biochemical Journal · doi:10.1042/bj20120731 · Cited by 96
AMP-activated protein kinase as a key molecular link between metabolism and clockwork
Lee, Y., & Kim, E.-K. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.65 · Cited by 93
Regulation of AMPK by the Ubiquitin Proteasome System
Zungu, M., Schisler, J. C., Essop, M. F., McCudden, C. R., Patterson, C., & Willis, M. S. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.030 · Cited by 103
The autophagy initiator ULK1 sensitizes AMPK to allosteric drugs
Dite, T. A., Ling, N. X. Y., Scott, J. W., Hoque, A., Galić, S., Parker, B. L., Ngoei, K. R. W., Langendorf, C. G., O’Brien, M. T., Kundu, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00628-y · Cited by 97
Self-citationMolecular evolution of Phox-related regulatory subunits for NADPH oxidase enzymes
Kawahara, T., & Lambeth, J. D. (2007) · BMC Evolutionary Biology · doi:10.1186/1471-2148-7-178 · Cited by 93
Peña-Münzenmayer, G., Catalán, M. A., Cornejo, I., Figueroa, C. D., Melvin, J. E., Niemeyer, M. I., Cid, L. P., & Sepúlveda, F. V. (2005) · Journal of Cell Science · doi:10.1242/jcs.02525 · Cited by 98
AMP-activated protein kinase: the guardian of cardiac energy status
Hardie, D. G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422683 · Cited by 93
Self-citationIncreased α2 Subunit–Associated AMPK Activity and PRKAG2 Cardiomyopathy
Ahmad, F., Arad, M., Musi, N., He, H., Wolf, C., Branco, D., Perez-Atayde, A. R., Stapleton, D., Bali, D., Xing, Y., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.550806 · Cited by 93
Day, P., Sharff, A., Parra, L., Cleasby, A., Williams, M., Hörer, S., Nar, H., Redemann, N., Tickle, I., & Yon, J. (2007) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444907009110 · Cited by 91
Functional modulation of AMP-activated protein kinase by cereblon
Lee, K. M., Jo, S., Kim, H., Lee, J., & Park, C.-S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.005 · Cited by 93
Ramon, M., Ruelens, P., Li, Y., Sheen, J., Geuten, K. P., & Rolland, F. (2013) · The Plant Journal · doi:10.1111/tpj.12192 · Cited by 110
Structural Properties of AMP-activated Protein Kinase
Riek, U., Scholz, R., Konarev, P., Rufer, A., Suter, M., Nazabal, A., Ringler, P., Chami, M., Müller, S. A., Neumann, D., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708379200 · Cited by 91
AMP-activated protein kinase and the metabolic syndrome
Fryer, L. G. D., & Carling, D. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330362 · Cited by 91
Khatri, N., & Man, H.-Y. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00199 · Cited by 90
Hirata, Y., Funato, Y., Takano, Y., & Miki, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.551176 · Cited by 102
ATP-dependent modulation of MgtE in Mg2+ homeostasis
Tomita, A., Zhang, M., Jin, F., Zhuang, W., Takeda, H., Maruyama, T., Osawa, M., Hashimoto, K.-I., Kawasaki, H., Ito, K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00082-w · Cited by 87
MgATP Regulates Allostery and Fiber Formation in IMPDHs
Labesse, G., Alexandre, T., Vaupré, L., Salard, I., Lai‐Kee‐Him, J., Raynal, B. D. E., Bron, P., & Munier‐Lehmann, H. (2013) · Structure · doi:10.1016/j.str.2013.03.011 · Cited by 88
Metabolic activation of AMP kinase in vascular smooth muscle
Rubin, L. J., Magliola, L., Feng, X., Jones, A. W., & Hale, C. C. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00075.2004 · Cited by 88
AMP-activated protein kinase – not just an energy sensor
Hardie, D. G., & Lin, S. (2017) · F1000Research · doi:10.12688/f1000research.11960.1 · Cited by 100
Self-citationWang, L., Chen, X., Tang, B., Xiang, H., Klein–Szanto, A. J., & Kruger, W. D. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi224 · Cited by 87
Niemeyer, M. I., Yusef, Y. R., Cornejo, I., Flores, C. A., Sepúlveda, F. V., & Cid, L. P. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00070.2004 · Cited by 87
Oliveira, S. M., Zhang, Y.-H., Solis, R. S., Isackson, H., Bellahcene, M., Yavari, A., Pinter, K., Davies, J. K., Ge, Y., Ashrafian, H., et al. (2012) · Circulation Research · doi:10.1161/circresaha.111.259952 · Cited by 86
Hypothalamic AMP-Activated Protein Kinase Regulates Glucose Production
Yang, C. S., Lam, C. K. L., Chari, M., Cheung, G. W. C., Kokorovic, A., Gao, S., Leclerc, I., Rutter, G. A., & Lam, T. K. T. (2010) · Diabetes · doi:10.2337/db10-0221 · Cited by 86
Serrano-Marco, L., Barroso, E., Kochairi, I. E., Palomer, X., Michalik, L., Wahli, W., & Vázquez‐Carrera, M. (2011) · Diabetologia · doi:10.1007/s00125-011-2401-4 · Cited by 92
Regulation of Autophagy by Glucose in Mammalian Cells
Moruno, F., Pérez-Jiménez, E., & Knecht, E. (2012) · Cells · doi:10.3390/cells1030372 · Cited by 86
Hutchinson, D. S., Summers, R. J., & Bengtsson, T. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.008 · Cited by 100
Structural Insight into AMPK Regulation: ADP Comes into Play
Jin, X., Townley, R. A., & Shapiro, L. S. (2007) · Structure · doi:10.1016/j.str.2007.07.017 · Cited by 94
Metadata
- Authors
- Scott, J. W., Hawley, S. A., Green, K. A., Anis, M., Stewart, G., Scullion, G. A., Norman, D. G., & Hardie, D. G.
- Affiliations
- University of Dundee (GB)
- Venue
- Journal of Clinical Investigation
- Published
- 2004-01-15
- Volume
- 113
- Issue
- 2
- Pages
- 274-284
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC311435
- OpenAlex
- W2166714586
- Cited by
- 754
- References
- 56
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 19 · 2023: 16 · 2022: 18 · 2021: 19 · 2020: 19 · 2019: 23 · 2018: 27 · 2017: 37 · 2016: 25 · 2015: 22 · 2014: 33 · 2013: 35 · 2012: 59
- FWCI
- 21.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Wellcome Trust (QLG1-CT-2001-01488)
- European Commission
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- CBS domain, energy sensing, AMPK, cystathionine beta-synthase, S-adenosylmethionine, pathogenic variants, genetic disorders, nucleotide binding site
- MeSH terms
- Adenosine, Adenosine Monophosphate, Adenosine Triphosphate, Allosteric Site, Animals, Binding Sites, Cloning, Molecular, DNA, Dose-Response Relationship, Drug, Escherichia coli, Glutathione Transferase, Humans, Kinetics, Ligands, Liver, Models, Molecular, Mutation, Plasmids, Protein Binding, Recombinant Fusion Proteins, Recombinant Proteins, Retinitis Pigmentosa, Polymerase Chain Reaction, Protein Structure, Tertiary, DNA, Complementary, Dimerization, Protein Isoforms, Amino Acid Motifs, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.